Details for New Drug Application (NDA): 020984
✉ Email this page to a colleague
The generic ingredient in RAPLON is rapacuronium bromide. Additional details are available on the rapacuronium bromide profile page.
Summary for 020984
Tradename: | RAPLON |
Applicant: | Organon Usa Inc |
Ingredient: | rapacuronium bromide |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 100MG/VIAL | ||||
Approval Date: | Aug 18, 1999 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 200MG/VIAL | ||||
Approval Date: | Aug 18, 1999 | TE: | RLD: | No |
Expired US Patents for NDA 020984
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Organon Usa Inc | RAPLON | rapacuronium bromide | INJECTABLE;INJECTION | 020984-001 | Aug 18, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Organon Usa Inc | RAPLON | rapacuronium bromide | INJECTABLE;INJECTION | 020984-002 | Aug 18, 1999 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription